Prostate Cancer - Results from #18760

Long-term efficacy and safety of enzalutamide monotherapy in hormone-naïve prostate cancer: 1- and 2-Year open-label follow-up results - Abstract April 10, 2015

Adherence to abiraterone among the first 86 recipients after release in Saskatchewan - Abstract April 9, 2015

Does the addition of targeted prostate biopsies to standard systemic biopsies impact treatment management for radiation oncologists? - Abstract April 8, 2015

Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy - Abstract April 8, 2015

Metformin association with lower prostate cancer recurrence in type 2 diabetes: A systematic review and meta-analysis - Abstract April 8, 2015

Gastrointestinal metastases from prostate cancer: A review of the literature - Abstract April 8, 2015

Therapeutic outcomes of neoadjuvant and concurrent androgen-deprivation therapy and intensity-modulated radiation therapy with gold marker implantation for intermediate-risk and high-risk prostate cancer - Abstract April 8, 2015

The serum luteinizing hormone level is significantly associated with recovery of urinary function after radical prostatectomy - Abstract April 8, 2015

Robotic or open radical prostatectomy after previous open surgery in the pelvic region - Abstract April 8, 2015

Exponential rise in prostate-specific antigen (PSA) during anti-androgen withdrawal predicts PSA flare after docetaxel chemotherapy in patients with castration-resistant prostate cancer - Abstract April 8, 2015

A simple-to-use method incorporating genomic markers into prostate cancer risk prediction tools facilitated future validation - Abstract April 8, 2015

Tasquinimod: How to act on microenvironment in metastatic prostate cancer - Abstract April 8, 2015

Focal ablation targeted to the index lesion in multifocal localised prostate cancer: A prospective development study - Abstract April 8, 2015

Improving the specificity of screening for lethal prostate cancer using prostate-specific antigen and a panel of kallikrein markers: A nested case-control study - Abstract April 8, 2015

Combination of multi-parametric magnetic resonance imaging (mp-MRI) and transperineal template-guided mapping biopsy (TTMB) of the prostate to identify candidates for hemi-ablative focal therapy - Abstract April 8, 2015

The role of radiotherapy in node-positive prostate cancer - Abstract April 8, 2015

The role of pathology correlation approach in prostate cancer index lesion detection and quantitative analysis with multiparametric MRI - Abstract April 8, 2015

Fractionated changes in prostate cancer radiotherapy using cone-beam computed tomography - Abstract April 8, 2015

Neoadjuvant luteinizing-hormone-releasing hormone agonist plus low-dose estramustine phosphate improves prostate-specific antigen-free survival in high-risk prostate cancer patients: A propensity score-matched analysis - Abstract April 7, 2015

The natural course of pT2 prostate cancer with positive surgical margin: Predicting biochemical recurrence - Abstract April 7, 2015

Page 939 of 1458